Perrigo Announces FDA Final Approval For Generic Version Of Androgel

Buy Lab Tests Online

Nelson Vergel

Founder, ExcelMale.com
Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing AbbVie Inc.'s Androgel® Topical Gel, 1.62% packets (20.25 mg/1.25 g packet and 40.5 mg/2.5 g packet).

Androgel® Topical Gel, 1.62% packets is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Annual market sales for Androgel® Topical Gel, 1.62% packets for the 12 months ending May 2017 were approximately $88 million.

Perrigo Executive Vice President and President Rx Pharmaceuticals John Wesolowski stated, "This final approval is another example of our long-term investment in new products. The Rx team remains committed to providing affordable treatments options for patients in important extended topical categories."

Source
 
Defy Medical TRT clinic doctor
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

enclomiphene
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
4
Guests online
5
Total visitors
9

Latest posts

bodybuilder test discounted labs
Top